Pipeline — registered trials by phase
A Prospective, Observational, Drug Utilization Study of Subjects Taking Truvada for Pre-exposure Prophylaxis in the USA
— · Pre-exposure Prophylaxis for Prevention of HIV Infection · Completed · est. 2018-01-22
Peripheral Body Fat Distribution After Switching Zidovudine and Lamivudine to Truvada
— · HIV-1 · Completed · est. 2008-03
A Phase 4 Cross-Sectional Study of Bone Mineral Density in HIV-1 Infected Subjects
— · HIV Infections · Completed · est. 2014-10
ROCKET II - Randomized Open Label Switch for Cholesterol Elevation on Kivexa + Kaletra Evaluation Trial
— · HIV-1 · Completed · est. 2009-09
Use-Results Surveillance Study of Harvoni® in Japanese Patients With Chronic Genotype 1 Hepatitis C Virus Infection
— · Hepatitis C · Completed · est. 2017-11-01
Safety Profile of Idelalisib in Patients With Refractory Follicular Lymphoma
— · Follicular Non-Hodgkin's Lymphoma Refractory · Completed · est. 2021-10-29
Effectiveness, Safety, Adherence, and Health-related Quality of Life in HIV-1 Infected Adults Receiving Bictegravir/ Emtricitabine/Tenofovir Alafenamide (B/F/TAF)
— · HIV-1-infection · Completed · est. 2022-03-21
Gilead Sustained Virologic Response (SVR) Registry
— · Hepatitis C, Chronic · Completed · est. 2017-03-28
CHARM: Chronic Hepatitis B Antihepadnaviral Resistance Mutation Study
— · Chronic Hepatitis B · Completed · est. 2008-10
SONETT: Switch Study to Once Daily HIV Treatment Regimen With Truvada
— · HIV-1 Infection · Completed · est. 2006-10
Effectiveness, Safety, Adherence, and Health-related Quality of Life in HIV-1 Infected Adults Receiving Bictegravir/ Emtricitabine/Tenofovir Alafenamide
— · HIV-1-infection · Completed · est. 2024-06-03
Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Voxilaprevir in Adults With Chronic Hepatitis C Virus Infection
— · Hepatitis C Virus Infection · Completed · est. 2014-12-22
A Study of PMPA in HIV-Infected Patients
— · HIV Infections · Completed
The Safety and Effectiveness of Zidovudine Plus Adefovir in HIV-Infected Patients
— · HIV Infections · Completed
A Phase 1 Study to Evaluate the Pharmacokinetics, Metabolism, and Excretion of GS-5806
— · RSV Infection · Completed · est. 2013-04
A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection
— · Hepatitis B · Completed · est. 2013-11
Pharmacokinetics of Voxilaprevir in Adults With Normal Renal Function and Severe Renal Impairment
— · HCV Infection · Completed · est. 2015-09-28
Dose Escalation Study of CAL-101 in Select Relapsed or Refractory Hematologic Malignancies
— · Chronic Lymphocytic Leukemia (CLL), Lymphoma, Non-Hodgkin (NHL), Acute Myeloid Leukemia (AML) · Completed · est. 2011-12
Study of Brexucabtagene Autoleucel (KTE-X19) in Participants With Relapsed/Refractory Mantle Cell Lymphoma (Cohort 3)
— · Relapsed/Refractory Mantle Cell Lymphoma · Completed · est. 2025-06-17
Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination and Sofosbuvir + Ribavirin for Subjects With Chronic Hepatitis C Virus (HCV) and Inherited Bleeding Disorders
— · Chronic HCV Infection · Completed · est. 2015-08
Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant
— · Hepatitis C, Hepatocellular Carcinoma · Completed · est. 2014-05
Substudy-01: A Study of Long-Acting HIV-1 Treatments Taken by Mouth in People With HIV-1 With Undetectable Virus Levels
— · HIV-1 Infection · Not Yet Recruiting · est. 2027-08
Presatovir in Lung Transplant (LT) Recipients With Respiratory Syncytial Virus (RSV) Infection
— · Respiratory Syncytial Virus (RSV) · Completed · est. 2017-02-20
Safety, Tolerability and Antiviral Activity of Selgantolimod in Virally-Suppressed Participants With Chronic Hepatitis B
— · Chronic Hepatitis B · Completed · est. 2019-03-22
Sofosbuvir in Combination With Pegylated Interferon and Ribavirin and in Treatment-Naive Hepatitis C-infected Patients
— · Hepatitis C Virus · Completed · est. 2011-04
Study to Evaluate Switching From a Regimen Consisting of the Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen (STR) to the Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate STR
— · HIV-1 Infection · Completed · est. 2011-07
A Study of Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C
— · Hepatitis C, Chronic · Completed · est. 2013-01
Safety and Efficacy Study of 90Y-hPAM4 at Different Doses
— · Pancreatic Cancer · Completed · est. 2007-10
Study of TUB-040 Given With Standard Ovarian Cancer Drugs in Patients With Fast-growing Ovarian Cancer
— · Ovarian Cancer · Recruiting · est. 2028-03
Evaluation of the Quality of Life Questionnaire-Bronchiectasis (QOL-B) in Patients With Bronchiectasis
— · Bronchiectasis · Completed · est. 2009-10
Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients
— · Gout · Completed · est. 2012-02
GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C Virus
— · Hepatitis C, Chronic · Completed · est. 2013-06
Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination +/- Ribavirin in Adolescents and Children With Chronic HCV-Infection
— · Hepatitis C Virus Infection · Completed · est. 2018-06-15
Study of TUB-040 in Patients With Recurrent or Progressive Uterine Cancer After Chemotherapy and Immune Therapy
— · Uterine Endometrial Cancer · Not Yet Recruiting · est. 2029-09
Study to Evaluate the Efficacy and Safety of Selonsertib in Participants With Moderate to Advanced Diabetic Kidney Disease
— · Diabetic Kidney Disease · Completed · est. 2021-09-03
Efficacy and Safety of Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF)-Containing Regimens in Participants With Chronic Hepatitis B Virus (HBV) Infection and Stage 2 or Greater Chronic Kidney Disease Who Have Received a Liver Transplant
— · Chronic Hepatitis B · Completed · est. 2018-02-08
Study Comparing Tenofovir Disoproxil Fumarate (TDF), Emtricitabine (FTC)/TDF, and Entecavir (ETV) in the Treatment of Chronic HBV in Subjects With Decompensated Liver Disease.
— · Chronic Hepatitis B · Completed · est. 2011-04
Ledipasvir/Sofosbuvir Fixed-Dose Combination + Ribavirin in Subjects With Chronic HCV With Advanced Liver Disease or Post-Liver Transplant
— · Chronic HCV Infection · Completed · est. 2015-01
Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
— · Acquired Immunodeficiency Syndrome, HIV Infections · Completed · est. 2012-10-17
Phase 2 Extension Study of Ambrisentan in Pulmonary Arterial Hypertension
— · Pulmonary Hypertension · Completed · est. 2009-12
Selonsertib in Combination With Prednisolone Versus Prednisolone Alone in Participants With Severe Alcoholic Hepatitis (AH)
— · Alcoholic Hepatitis (AH) · Completed · est. 2018-02-16
Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Adults With Chronic HCV and HBV Coinfection
— · Hepatitis C Virus Infection · Completed · est. 2017-01-04
Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected Children
— · HIV Infections · Completed · est. 2009-04-06
Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Participants With HR+/HER2- Metastatic Breast Cancer
— · Metastatic Breast Cancer · Completed · est. 2023-10-20
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
— · Coronary Artery Disease, Angina Pectoris · Completed · est. 2015-02
Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF
— · Cystic Fibrosis · Completed · est. 2015-01
Evaluate Efficacy, Safety and PK of Adefovir Dipivoxil Liquid Suspension in Patients With Chronic Hepatitis B
— · Chronic Hepatitis B · Completed · est. 2006-03
Study of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Participants With Relapsed/Refractory Follicular Lymphoma
— · Relapsed/Refractory Follicular Lymphoma · Active Not Recruiting · est. 2030-10
Sofosbuvir + Ribavirin for 12 Weeks in Subjects With Chronic Genotype 2 or 3 Hepatitis C Infection Who Are Interferon Intolerant, Interferon Ineligible or Unwilling to Take Interferon
— · Chronic Hepatitis C · Completed · est. 2012-11
Study to Evaluate the Antiviral Efficacy, Safety and Tolerability of Tenofovir Disoproxil Fumarate Versus Placebo in Pediatric Participants With Chronic Hepatitis B Infection
— · Chronic Hepatitis B · Active Not Recruiting · est. 2017-08-07
Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Participants With Chronic Genotype 1 HCV Infection
— · Chronic HCV Infection · Completed · est. 2017-07-08
Study to Evaluate the Safety and Efficacy of E/C/F/TAF Versus E/C/F/TDF in HIV-1 Positive, Antiretroviral Treatment-Naive Adults
— · HIV, HIV Infections · Completed · est. 2014-09-19
Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1 Infected Adolescents
— · HIV · Completed · est. 2016-11-10
ADVANCE MPI 2: Study of Regadenoson Versus Adenoscan® in Patients Undergoing Myocardial Perfusion Imaging (MPI)
— · Coronary Artery Disease · Completed · est. 2005-06
Study of Obeldesivir in Nonhospitalized Participants With COVID-19
— · COVID-19 · Completed · est. 2023-11-28
Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor Plus Emtricitabine/Tenofovir Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients
— · Acquired Immunodeficiency Syndrome, HIV Infections · Completed · est. 2013-11
Study of Sacituzumab Govitecan Versus Physician's Choice of Treatment in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread
— · Locally Advanced or Metastatic Unresectable Urothelial Cancer · Completed · est. 2025-07-04
DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant Hypertension
— · Hypertension · Completed · est. 2009-08
Tenofovir Disoproxil Fumarate (Tenofovir DF) Versus Emtricitabine/Tenofovir DF in Subjects Resistant to Lamivudine
— · Hepatitis B · Completed · est. 2011-11
Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) Infection
— · Hepatitis C Virus Infection · Completed · est. 2018-02-07
Safety of AZLI in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa in the Lower Airways
— · Cystic Fibrosis, Pseudomonas Aeruginosa · Completed · est. 2013-04
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
— · Type 2 Diabetes Mellitus · Completed · est. 2013-08
Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 or 4 HCV and HIV-1 Co-infection
— · Hepatitis C Virus, HIV · Completed · est. 2014-11
Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment Naive, HIV-1 and Hepatitis B Co-Infected Adults
— · HIV-1/HBV Co-Infection · Completed · est. 2022-02-25
Sofosbuvir + Ribavirin for 12 or 16 Weeks in Treatment Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection (FUSION)
— · Chronic Hepatitis C · Completed · est. 2013-02
CaystonAztreonam
EmtrivaEmtricitabine
LetairisAmbrisentan
TruvadaEmtricitabine
Source: ClinicalTrials.gov (trials where Gilead is lead sponsor; 65 active or completed) and Drugs@FDA (4 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- N-PX2026-08-26N-PX
- SCHEDULE 13D/A2026-08-07SCHEDULE 13D/A
- S-3ASR2026-08-06S-3ASR
- 10-Q2026-08-06Quarterly report
- 8-K2026-08-04Current report (material event)
- 13F-HR2026-08-0313F-HR
- SCHEDULE 13D/A2026-05-27SCHEDULE 13D/A
- 8-K2026-05-20Current report (material event)
- 424B52026-05-18Prospectus (offering)
- FWP2026-05-14FWP
- 424B52026-05-14Prospectus (offering)
- 13F-HR2026-05-0813F-HR
- S-82026-05-07Employee stock plan
- 10-Q2026-05-07Quarterly report
- 8-K2026-05-07Current report (material event)
- 8-K2026-05-04Current report (material event)
- SCHEDULE 13G2026-04-29SCHEDULE 13G
- SCHEDULE 13D/A2026-04-28SCHEDULE 13D/A
- 8-K2026-04-28Current report (material event)
- SC TO-T/A2026-04-28SC TO-T/A
- SC TO-T/A2026-04-17SC TO-T/A
- SC TO-T/A2026-04-01SC TO-T/A
- SCHEDULE 13G/A2026-03-26SCHEDULE 13G/A
- ARS2026-03-20Annual report to holders
- DEFA14A2026-03-20DEFA14A
- DEF 14A2026-03-20Proxy statement
- SC TO-T2026-03-06SC TO-T
- 10-K2026-02-24Annual report
- SC TO-C2026-02-23SC TO-C
- SCHEDULE 13D2026-02-23SCHEDULE 13D
- SC TO-C2026-02-23SC TO-C
- 8-K2026-02-23Current report (material event)
- SCHEDULE 13G/A2026-02-12SCHEDULE 13G/A
- 13F-HR2026-02-1213F-HR
- SCHEDULE 13G/A2026-02-12SCHEDULE 13G/A
- 8-K2026-02-10Current report (material event)
- SCHEDULE 13G2026-02-05SCHEDULE 13G
- 8-K2025-11-19Current report (material event)
- 13F-HR2025-11-1313F-HR
- 10-Q2025-11-07Quarterly report
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.